Search Results for "Saleh Stevens Continental Clinical Solutions"

17:58 EDT 21st October 2016 | BioPortfolio

Matching Channels


Latin America

Latin America encompasses the Caribbean, South America and Central America. These countries are important players in the biotechnology industry, not only as consumers, but as contributors. The env...


Baxter is one of the 30 largest pharmaceutical companies in the world with annual sales of $7.8 billion. With a foot in both the pharmaceutical industry and medical devices, Baxter Healthcare has ...

TASH Biotechnology

Shanghai TASH Biotechnology Co.,Ltd. specializes in peptide development on the basis of high technology. TASH Biotechnology are focusing on custom peptide synthesis, and the research, development...

Matching News

Piramal Enterprises Acquires Ash Stevens

Piramal Enterprises inked an agreement to acquire Ash Stevens, a U.S. based contract development and manufacturing organization for $42.95 million plus an earn-out consideration capped at $10 millio...

Ash Stevens acquired by Indian CDMO

Ash Stevens has announced that it has been acquired by Piramal Pharma Solutions, an India-based CDMO, in a deal worth $42.95m

Piramal to Acquire CDMO Ash Stevens for US$53M

US-based Ash Stevens will add high potency capabilities to the services that the Indian firm offers. The post Piramal to Acquire CDMO Ash Stevens for US$53M appeared first on PharmaAsia.

Ash Stevens acquired by India-based CDMO

Ash Stevens has been acquired by Piramal Pharma Solutions, an India-based CDMO, in what the CEO said is an "incredibly powerful combination."

Stevens Institute of Technology Launches $150 Million Campaign

Hoboken, NJ (PRWEB) May 11, 2016 Stevens Institute of Technology has announced the launch of a new $150 million, three-year campaign...

Piramal: $53m Ash Stevens addition ‘synergistic’ with ADC business

The acquisition of Ash Stevens and a US high potent API facility will bolster Piramal’s antibody-drug conjugate offerings, the Indian CDMO says.

Fire Door Solutions Expanding its Presence across Country

(PRWEB) June 14, 2016 Fire Door Solutions, headquartered in Overland Park, Kansas, in response to CMS’ adoption of the 2012 Lif...

Yasmine Saad, Ph.D., is recognized by Continental Who's Who

NEW YORK, Oct. 7, 2016 /PRNewswire/ -- Yasmine Saad, Ph.D., is recognized by Continental Who's Who as a Pinnacle Professional in the field of Psychology. Dr. Saad is a clinical psychologist, who ...

Matching PubMed Articles

9 years of a single referral centre management of Stevens - Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) corresponds to a rare and acute life-threatening mucocutaneous reactions characterized by extensive necrosis and epidermal detachmen...

The Aryne 2,3 Stevens Rearrangement.

Arynes are employed in the transition-metal-free and mild [2,3] Stevens rearrangement of tertiary allylic amines for the synthesis of functionalized homoallylic amines in moderate to good yield with a...

Ocular manifestations of Stevens-Johnson syndrome and their management.

Recent advances and outcomes data in the management of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) demonstrate the need for a universal standard of care for patients admitted wit...

Pre-Clinical MRI-Guided Focused Ultrasound: A Review of Systems and Current Practices.

Effective pre-clinical research is a vital component in the development of MRI-guided focused ultrasound (MRgFUS) and its translation to clinic. In this review we seek to outline the challenges at han...

Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.

Search Whole site using Google

Quick Search
Advertisement Advertisement